Timothy P. Walbert - Sep 30, 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Sep 30, 2021
Transactions value $
-$5,515,140
Form type
4
Date filed
10/1/2021, 04:08 PM
Previous filing
Aug 27, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -108K -12.71% $0.00 740K Sep 17, 2021 Direct
transaction HZNP Ordinary Shares Gift $0 +108K $0.00 108K Sep 17, 2021 See footnote F1
transaction HZNP Ordinary Shares Gift $0 -111K -14.93% $0.00 629K Sep 17, 2021 Direct
transaction HZNP Ordinary Shares Gift $0 +111K +526.35% $0.00 131K Sep 17, 2021 By Spouse
transaction HZNP Ordinary Shares Sale -$3.35M -30.5K -4.84% $109.96 599K Sep 30, 2021 Direct F2, F3
transaction HZNP Ordinary Shares Sale -$2.1M -18.9K -3.16% $110.80 580K Sep 30, 2021 Direct F2, F4
transaction HZNP Ordinary Shares Sale -$67.2K -600 -0.1% $112.01 579K Sep 30, 2021 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Timothy P. Walbert Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.48 to $110.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.48 to $111.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.73 to $112.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.